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1. Introduction
1.1. Overview and pathogenesis
The discovery of the association of Helicobacter pylori with chronic gastritis, peptic ulcers and
gastric neoplasia, mucosa-associated lymphoid tissue-type lymphoma and carcinoma, has
led to fundamental changes in the understanding of gastric disease in humans. Some hu‐
mans with H. pylori infection develop only mild, asymptomatic gastritis. Whether more se‐
vere disease develops thought to be influenced by individual host factors and pathogenicity
of the bacteria involved. The odd of developing symptomatic H. pylori infection varies by
geographic location and age. Different strains of H. pylori have recently been identified.
Therefore, H. pylori should be considered a population of closely related but genetically het‐
erogenous bacteria of different genotypes and virulence.
A  gastric  spiral  bacteria  of  superkingdom  bacteria,  phylum  proteobacteria,  subphylum
delta/epsilon subdivisions, class epsilonproteobacteria, order campylobacter, family helico‐
bacteraceae,  genus  Helicobacter  spp.  is  gram-negative,  spiral-shaped  bacteria.  At  least  13
species have been reported,  and most are suspected or proven gastric  or hepatic patho‐
gens.  Helicobacter  spp.  have  been  reported  in  humans:  mainly  H.  pylori,  nonhuman  pri‐
mates:  H.  nemestrinae,  cats  and  dogs  various  species,  including  H.  pylori,  H.  felis,  H.
salomonis, H. rappini, H. heilmannii, and H. bizzozeronii, pigs: H. heilmannii, ferrets: H. muste‐
lae,  and cheetahs: H. acinonys.  More recently we have learned that nearly all mammmals
harbor their own species of Helicobacter infection. Some are suggesting now that infection
might be benign or even beneficial  by protecting againts development of esophageal re‐
flux and cancer of the esophagus.
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Risk factors for H. pylori infection in humans include age and socioeconomic status, with
children and those with low socioeconomic status at greater risk. The role of Helicobacter spp.
in gastrointestinal disease in dogs and cats is uncertain. It has been known for years that
gastric Helicobacter-like organisms (HLO) are commonly present in stomach of dogs but the
relationship of these organisms and gastric disease is unresolved. H. pylori transmission is
proposed to be fecal-oral, oral-oral, and gastro-oral (via vomited fluids). The exact details of
transmission are still unclear. A higher incidence of H. pylori infection has been reported by
gastroenterologists, suggesting that transmission from patient to physician is possible. It has
been suggested that Helicobacter spp. infection might be zoonotic by contact with dogs and
cats and has been correlated with human H. heilmannii infection. There is no correlation be‐
tween pet ownership and human H. pylori infection.
H. pylori is one of the major causes of chronic gastritis and plays an important role in the
pathogenesis of peptic ulcer, gastric carcinoma, gastric adenocarcinoma, and primary B-cell
gastric lymphoma. H. pylori is the second most common cause of cancer morbidity and mor‐
tality worldwide, and the development of gastric non-Hodgkin’s lymphoma. Histological
gastritis is essentially universal among H. pylori-infected individuals, but only a few develop
a clinically significant outcome, such as peptic ulcer disease or gastric cancer. The clinical
significance of this bacterium has recently been emphasized by a National Institutes of
Health consensus panel and thus recommending antibiotic therapy for the large majority of
peptic ulcer patients who are infected with H. pylori and by classification of H. pylori as a
classification of H. pylori as a class I (definite) carcinogen by the World Health Organization.
The bacteria were often seen in malignant or ulcerated gastric tissue, and the possibility of
an infectious cause of peptic ulcer was considered. H. pylori often estabishes life-long infec‐
tions of the gastric mucosa. These bacteria produce a powerful urease that is regulated in
response to acid. So the ammonia and carbonate produced by this enzyme most likely create
an alkaline microenvironment. This mechanism is unprecedented. Further study shows that
the high density of colonization by H. pylori occurs in the antrum (lower portion of the stom‐
ach) where conditions are less acidic. As the infection becomes more pronounced or under
conditions where the antrum becomes more alkaline, the motile bacteria migrate up into the
cardia (body) of the stomach. Infection with H. pylori bacteria is basically located in three di‐
mensions, as these bacteria not only can move north and south in the mucosa in response to
acid levels, but they are able to move freely up and down in the mucus layer that coats the
gastric mucosa and provides a protective barrier against the diffusion of strong acid onto the
epithelium. The notion of being ”off shore” and therefore out of reach of the macrophages
and cells of host immune defense may also play an important role in survival of these bacte‐
ria. Finally, the mounting evidence suggests that H. pylori may control the immune response
and selective release of inflammatory factors. The balance between increase of inflammation
and immune suppression is a key to the persistence and an area where novel therapeutics,
perhaps in combination with vaccine strategies, could be directed.
The discovery of Helicobacter spp., a relative of Campylobacter spp. (bacterial pathogens of the
lower GI tract), fortunately coincided with the beginning of the genomics era, and is the ben‐
eficiary of two completely sequenced genomes of H. pylori. The results reveal a small ge‐
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nome (1.67 megabases) containing some 1553 genes encoding around 1,300 proteins. Despite
possessing a limited number of genes, H. pylori displays auxotropy for only a few amino
acids and appears to possess most catabolic and anabolic pathways found in bacteria with
larger genomes. Recent studies examining essentiality testing on a genome scale suggested
that there are few redundancies and backups in metabolic pathways and thus the percent‐
age of H. pylori genes found essential may be greater than expected for organisms with larg‐
er genomes perhaps opening a door for development of Helicobacter selective therapeutics.
Helicobacter-like bacteria have been identified in the stomachs of all mammalian species ex‐
amined to date. Many epidemiological studies have shown a strong association between
chronic H. pylori infection and subsequent development of gastric carcinoma in humans.
Studies of H. pylori and gastric carcinoma from the view point of animal model showed that
persistent H. pylori infection has recently been achieved in the Japanese monkeys and Mon‐
golian gerbil models, with results demonstrating that the sequential histopathological
changes in the gastric mucosa are closely mimic the gastric mucosal changes caused by H.
pylori infection in humans. Gastric mucosa infected with H. pylori exhibited significantly
higher gastritis score, reduction in glandular height, increase in the number of Ki-67 positive
cells and over expression of p53 protein and p53 gene mutation in the Japanese monkey
model. In the Mongolian gerbil model, H. pylori infection enhances gastric and also demon‐
strated that H. pylori infection alone can result in the development of gastric carcinoma
In gnotobiotic dogs were used as experimental hosts for H. pylori infection. All dogs test‐
ed were successfully colonized with H. pylori. In addition, two inoculated dogs co-housed
with experimental dogs also became colonized which indicating transmission of infection.
The  subsequent  use  of  dogs  as  H.  pylori  models  has  been  limited.  One  recent  study
showed that conventionally housed dogs are also susceptible to experimental infection. In
addition to experimental studies, efforts have been made to determine the presence of nat‐
ural gastric Helicobacter spp. infections in dogs. Surveys of pet dogs have repeatedly failed
to show natural infection with H. pylori. However, natural infection with other gastric Hel‐
icobacters commonly occurs. H. felis, H. bilis, H. bizzozeronii, H. salomonis, H. heilmannii and
Flexispira rappini have all been identified in surveys of gastric infections in dogs. A signif‐
icant  association  between their  presence  and the  occurrence  of  gastritis  has  never  been
demonstrated. There have been many studies confirm other studies which suggested the
presence of Helicobacter spp. is naturally found in dogs. It has been reported that the gas‐
tric biopsies found Helicobacter-like organism infection and dogs were postulated to be in‐
fected with several species of Helicobacter  spp.  While, it is said to be the most commonly
occurring of Helicobacter-like organisms in dogs and cats. The role of Helicobacter spp. infec‐
tion in gastrointestinal disease in dogs and cats is uncertain. It has been known for years
that gastric Helicobacter-like organisms (HLO) are commonly presented in stomach of dogs
but the relationship of these organisms and gastric disease is  unresolved. Infection with
HLO is highly prevalent in dogs. It is seen the clinical sign of vomiting and also clinical‐
ly healthy pet dogs.  Gastrospirillum hominis,  another Helicobacter-like organism, has so far
not been cultivated.
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H. pylori transmission is proposed to be fecal-oral, oral-oral, and gastro-oral (via vomited
fluids). The exact details of transmission are still unclear. A higher incidence of H. pylori in‐
fection has been reported by gastroenterologists, suggesting that transmission from patient
to physician is possible. It has been suggested that Helicobacter spp. infection might be zoo‐
notic by contact with dogs and cats and has been correlated with human H. heilmannii infec‐
tion. There is no correlation between pet ownership and human H. pylori infection.
Helicobacter spp. produce urease, which breaks down urea into ammonia and bicarbonate
ions. In stomach, ammonia has a buffering effect that may help Helicobacter spp. colonize on
mucosa in the acidic gastric environment. In addition, ammonia is directly toxic to gastric
epithelial cells. H. pylori infection is associated with increased gastric acid secretion (hyper‐
acidity), which causes inflammation of the gastric antrum (antral gastritis) and duodenal ul‐
ceration. It has been proposed that hyperacidity is caused by hypergastrinemia resulting
from the inhibition of somatostatin-secreting cells (somatostatin inhibits gastrin release). Hy‐
pergastrinemia also increases parietal cell mass through a trophic effect on gastric mucosa.
H. pylori infection can also be associated with lack of gastric acid (achlorhydria). This is
thought to occur when H. pylori causes mucosal atrophy in the gastric fundus and body or
inhibits functioning of the parietal cells. Chronic gastric inflammation may progress to
chronic atrophic gastritis and intestinal metaplasia, which are precancerous conditions. It
appears that Helicobacter spp. infection significantly alter gastric acid secretion in dogs.
The pathological significance of these organisms in the dog is currently unknown. Study of
naturally infected dogs and cats has shown that Helicobacter spp. predominantly colonizes
the gastric fundus and cardia and is associated with mild to moderate mononuclear cell in‐
flammation in appearance of chronic gastritis. In an experimental study of beagles which in‐
fected with H. felis and H. bizzozeronii-like organisms, it has been concluded that acid
secretion was not markedly disturbed by infection and that treatment had been temporarily
suppressed. Infected dogs showed no clinical signs and had mild gastritis histologically be‐
fore and after treatment. No correlation was identified between the severity of inflammation
and degree of bacterial colonization. It has been suggested that successful treatment of Heli‐
cobacter spp. in pet dogs did not change gastric histology and that mild chronic gastritis still
persisted.
1.2. Helicobacter diagnosis
Non-invasive test methods for detecting Helicobacter spp. (e.g., urea breath testing, antibody
testing, stool antigen testing) are not routinely available for dogs and cats. Urease testing
from breath and blood, has been investigated in dogs but is not widely available. Antibody
testing is potentially used but more difficulty apply than in human because of the variety of
Helicobacter spp. infecting dogs and cats. Nevertheless, antibody testing is being investigated,
and infected animals are known to develop antibodies. Theoretically, stool antigen testing
could be useful in H. pylori-infected cats or in animals infected with Helicobacter spp. that
have antigenic homology. Thus cross-reactivity with H. pylori should be concerned. This has
not yet been investigated. The confirmation of the presence of Helicobacter spp. in dogs and
cats, the invasive methods has already been discussed. Endoscopically obtained gastric mu‐
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cosal biopsies are commonly used, and direct observation of organisms by histology or cy‐
tology and rapid urease testing are common methods. Because of Helicobacter spp.
distribution in the stomach may be in locally site, evaluation of multiple biopsies and ana‐
tomic location (i.e., cardia, fundus, and antrum) is also recommended. Gastric Helicobacter
spp. was found in the cardia, fundus, body, and pylorus. It has been reported that the most
prevalent location of stomach were in cardia, fundus, body and pylorus respectively. In ad‐
dition, naturally infected dogs has shown that Helicobacter spp. predominantly colonizes in
the gastric cardia and fundus. Helicobacter spp. was demonstrated considerable affinity for
parietal cells and is found in their intracellular canaliculi as well as in the cytoplasm. They
had been observed in large numbers in the mucus covering the surface epithelium, the gas‐
tric pits and the glandular lumina. It appears that Helicobacter spp. infection does not signifi‐
cantly alter gastric acid secretion in dogs. Study of naturally infected dogs has shown that
Helicobacter predominantly colonizes the gastric cardia and fundus. However, the predilec‐
tion site of infection is recommended as fundic area of the stomach.
Direct observation of Helicobacter spp. organisms in biopsy specimens and necropsied dogs
usually requires special stains. It  has been reported that there was no statistically differ‐
ent significant between the locations of histopathological lesion and Helicobacter spp. infec‐
tion using H&E. The presence of lymphoid follicles in the gastric mucosa has traditionally
been considered a common, nonspecific finding in the gastric mucosa of dogs. Most dogs
had many bacteria and only mild gastritis.  It  is  suggested that in dogs, the bacteria did
not induce histological evident of certain diseases.  In naturally infected with Helicobacter
spp., the lymphoid follicles are frequently found in subglandular areas and sometimes ex‐
tended between the glands. Moreover, it was reported that, gnotobiotic dogs which exper‐
imentally  infected  with  Helicobacter  spp.  developed  large  numbers  of  lymphoid  follicles
throughout  the gastric  mucosa,  while  the dogs had no follicles.  The occurrence of  lym‐
phoid  follicles  were  indicated  the  Helicobacter  spp.  infection  from  gastrointestinal  speci‐
mens  which  depend  on  the  sites.  In  comparable  to  the  H.  pylori  infection  in  children
which frequently results in marked gastric lymphoid hyperplasia, have led to the hypoth‐
esis that lymphoid follicles in the human gastric mucosa can result from chronic H. pylori
antigenic  stimulation  and,  therefore,  represent  a  specific  immune  response  directed
against the organisms. Also, by inducing lymphoid tissue formation in the gastric muco‐
sa, H. pylori may be a necessary precursor for the development of primary gastric MALT
lymphoma. It  should be noted that the histopathological changes in the dogs was much
less severe than those seen in H. pylori gastritis in human which could be due to species
variation. It will be of interest to study dogs which have been subjected to different envi‐
ronmental conditions or dietary changes to ascertain if differences in the gastritis profile
occur with manipulation of these variables.
The Histopathology diagnosis,  Helicobacter  spp.  can be  visualized at  the  high magnifica‐
tion with conventional Hematoxylin & eosin (H&E) stained sections. Bacteria are located
in  the  mucus  adherent  to  the  surface  epithelium  and  are  often  found  deep  within  the
crypts. However, H&E staining may be unclear when few bacteria are also presented. In
addition, luminal debris on the surface of the epithelium can be mistaken for Helicobacter
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spp.  in H&E stained sections. Although these organisms with certain morphology 2.5-5.0
µm length, 0.5- 1.0 µm width and had five to nine helical turns could be notified. But the
other organisms such as Bacillus organisms were difficult to histology evaluation. Because
of the presented things were presented quite similar to Helicobacter spp.  in color by H&E
staining in histology evaluation (Fig. 1). Using special stains such as Warthin Starry stain
(WSS) facilitates histological identification of bacteria. Helicobacter spp. was obviously pre‐
sented in dark-brown color on yellow background. These bacteria were located mainly in
the gastric pits  and the upper portions of gastric glands,  where they were often in inti‐
mate association with the epithelial cell surface (Fig. 2). These bacteria were located with‐
in  the  gland  lumens,  sometimes  attached  to  the  epithelial  cell  surface,  and  within  the
cytoplasm of  parietal  cells.  WSS sections  of  stomach part  revealed tightly  coiled helical
bacteria  that  were generally  2.5-  5.0  µm length.  It  is  suggested that  WSS is  high occur‐
ence than H&E. It is likely that the additional of WSS is offset by a reduction in time re‐
quired for slide evaluation and improvement of identification of Helicobacter spp. infection.
A sensitive staining technique consisting of a combination of H&E and WSS has been de‐
veloped. WSS could be used for detecting Helicobacter spp.  in gastric tissues short period
of time, cheap and easy to use.  The WSS examination of large numbers of sections in a
relatively short period of time. However, the special staining procedure can be technical‐
ly difficult, and require experiences. Its meaning acceptance among gastrointestinal path‐
ologists  has  not  been  proved  yet.  Other  factors  that  could  influence  gastric  pathology
include the number of organisms present,  the host species and genotype, environmental
factors such as diet,  and concurrent infection with undetected organisms. However, it  is
suggested  the  significantly  different  correlations  for  Helicobacter  spp.  detection  between
H&E and WSS.  Therefore,  the  diagnostic  method of  choice  for  diagnosis  of  Helicobacter
spp. infection in canine stomach is depended on the purpose and appropriate site of speci‐
men collection.
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Figure 1. The numerous spiral shape organisms: Helicobacter spp. was presented in the surface of gastric mucosa in
fundus part of stomach in dog (Arrow) (A) (H&E, Bar = 10 µm) Helicobacter spp. was demonstrated on the gastric epi‐
thelium in higher magnification. (B) (H&E, Bar = 5 µm)
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Figure 2. Spiral-shape Helicobacter spp. was positive in dark brown color was showning 3.0 - 5.0 µm in length and 0.5
– 1.0 µm in width in the gastric pit in fundus. In higher magnification of spiral-shape with dark brown color of Helico‐
bacter spp. (WSS, A : Bar = 10 µm, B : Bar = 5 µm)
In case of Immunohistochemical staining, IHC was much more sensitive for detecting in‐
fection than the routinely used H&E and WSS. IHC staining also have been developed to
detect  Helicobacter  spp.  antigen.  The IHC using monoclonal anti-H. pylori  antibody is  the
best diagnostic tool for formalin-fixed samples (Fig. 3). And IHC is very high specificity.
But IHC is rather expensive, long period of time and good experience. Such IHC are usu‐
ally not necessary but may prove worthwhile in cases where stains are difficult to evalu‐
ate for confirmations.
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Figure 3. Helicobacter spp. demonstrated brown color in positive sites by Immunohistochemistry using rabbit polyclo‐
nal anti-H. pylori antibody in lumen of gastric gland in fundus part of stomach. Meyer’s Hematoxylin counterstained,
ABC, DAB (A Bar =20 µm, B Bar =10 µm)
For PCR offers great promise as a highly sensitive and specific technique for the detection of
Helicobacter spp. and H. pylori. PCR technique for the detection of H. pylori in gastric biopsy
specimens has been described by a number of laboratories although the accuracy of such
technique varies widely. The identification of Helicobacter spp. in biopsies from dogs using
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PCR has been reported and applied for detection of identification to species of Helicobacter
spp. in dogs with naturally occurring gastric helicobacteriosis. Several observations shown
that PCR was sensitive and specific which is in agreement with studies in mice infected with
H. felis and in humans and cats infected H. pylori, which showed that PCR was more sensi‐
tive than histology, bacterial culture, and urease mapping. Factors affecting test accuracy of
PCR include the choice of primers and target DNA, specimen preparation, bacterial density
and technical issues. PCR demonstrated excellent accuracy for the detection of H. pylori in‐
fection in a limited number of samples. PCR technique for the detection of H. pylori is still in
its infancy. It is unlikely that such technique will have widespread use in the initial detec‐
tion of H. pylori. However, PCR method hold great promise in the detection of genetic differ‐
ences between H. pylori strains for research and epidemiological studies. Repeat endoscopy
or biopsy is required, which is expensive and unappealing to many pet owners. However,
an advantage of follow up endoscopy in noninvasive testing is the opportunity to reassess
gastric morphologic changes.
2. Treatment
Treatment of the Helicobacter spp. infection in dogs is controversial. Whether treatment is
needed in all cases and which drugs are preferred. Efficacy of treatment and whether drug
resistance is a problem in veterinary patients and should be awared. Recent studies suggest‐
ed that treatment might only suppress infection but not eradicate it. More reports of post
treatment follow-up assessing bacterial status and gastrointestinal (GI) changes are needed
for naturally acquired clinical signs in a dog should be considered. A profile of investiga‐
tions to rule out underlying GI disease (e.g., food inflammatory bowel disease, neoplasia)
should be undertaken before treating Helicobacter spp. infection. Even with such a work set
up, it may be difficult to know whether all GI inflammation is caused by Helicobacter spp.
infection alone or whether underlying with other inflammatory diseases. This is especially
true for patients in which inflammation persists following treatment and apparent Helico‐
bacter spp. prevention and control.
The treatment protocols in dogs and cats have been adapted from human medicine and in‐
cluded various combination of antibiotic and antisecretory therapy. Traditional veterinary
triple therapy consists of metronidazole, amoxicillin, and bismuth subsalicylate and has
been used as initial treatment for Helicobacter spp. infection in dogs and cats. Other antimi‐
crobial drugs that have been used in animals in which traditional triple therapy fails include
tetracycline and clarithromycin. Antisecretory drugs that have been used include H2-recep‐
tor antagonists and proton-pump inhibitors. Treatment is typically administered for 2 to 4
weeks, but the optimal duration of treatment is unknown. The clinical gastritis resolve fol‐
lowing 4 weeks of treatment with traditional veterinary triple therapy (in dogs) or a combi‐
nation of amoxicillin, metronidazole, and famotidine (in dogs and cats). These therapeutic
protocol has been practically used.
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